Categories: DesignManufacturingTools
Terrain Bio helps RNA therapeutics companies design and build better RNA, faster. Leveraging the latest innovations in protein and RNA design and the deep expertise of its scientific cofounders, Terrain brings unparalleled speed and quality to RNA manufacturing.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.02.2025 | Seed | $9M | - |
Mentions in press and media 4
| Date | Title | Description |
| 14.02.2025 | Uscreen's $150 Million Leap: Empowering Creators in the Digital Age | In the ever-evolving landscape of the creator economy, Uscreen has emerged as a beacon of opportunity. The Washington, DC-based video monetization platform recently secured a staggering $150 million investment from PSG, a growth equity firm... |
| 14.02.2025 | Uscreen Receives $150M Investment from PSG | Uscreen, a Washington, DC-based provider of a video monetization platform for the creator economy, raised $150M in Investment form PSG.
The company intends to use the funds to expand and upgrade its native mobile and TV apps and build out a... |
| 14.02.2025 | Terrain Biosciences Raises $9M in Seed Funding | Terrain Biosciences, Cambridge, MA-based RNA design-build company, raised $9M in Seed funding.
Backers included Magnetic Ventures, Bruker Corporation, Josef Feldman, John Maraganore, Hans Bishop, and John Evans.
The company intends to use t... |
| - | Terrain Bio | “Terrain Bio helps RNA therapeutics companies design and build better RNA, faster. Leveraging the latest innovations in protein and RNA design and the deep expertise of its scientific cofounders, Terrain brings unparalleled speed and qualit... |
Reviews 0
